HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phase III randomized trial of amifostine as a radioprotector in head and neck cancer.

AuthorsB Vikram
JournalJournal of clinical oncology : official journal of the American Society of Clinical Oncology (J Clin Oncol) Vol. 19 Issue 4 Pg. 1233-4 (Feb 15 2001) ISSN: 0732-183X [Print] United States
PMID11181692 (Publication Type: Comment, Letter)
Chemical References
  • Radiation-Protective Agents
  • Amifostine
Topics
  • Amifostine (therapeutic use)
  • Head and Neck Neoplasms (radiotherapy, therapy)
  • Humans
  • Radiation-Protective Agents (therapeutic use)
  • Randomized Controlled Trials as Topic
  • Xerostomia (chemically induced)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: